Funding for this research was provided by:
National Institutes of Health (R01GM114472, R01HG005084, R01HG005853)
National Institute of Mental Health (R01MH097276)
National Science Foundation (0953881, IIS0916439)
Received: 5 March 2019
Accepted: 20 August 2019
First Online: 19 September 2019
: C.M., M.C. and C.B. are cofounders of, and hold equity in, Bridge Genomics, which is negotiating a licensing agreement with the University of Minnesota for the method used in this paper. The method is described in a pending patent (PCT/US17/22308). The University of Minnesota also has equity and royalty interests in Bridge Genomics. These interests have been reviewed and managed by the University of Minnesota in accordance with its Conflict of Interest policies. The remaining authors declare no competing interests.